# Breakthrough Dyspnea Fentanyl Study in Cancer Patients

> **NCT01515566** · PHASE1,PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 26 (actual)

## Conditions studied

- Advanced Cancers
- Dyspnea

## Interventions

- **DRUG:** Fentanyl
- **OTHER:** Placebo
- **OTHER:** Walking Tests
- **BEHAVIORAL:** Questionnaires

## Key facts

- **NCT ID:** NCT01515566
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01515566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01515566, "Breakthrough Dyspnea Fentanyl Study in Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01515566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*